MEDINET Co., Ltd.
2370・Growth Market・Services
MEDINET Co., Ltd.2370
MEDINET Co., Ltd.2370
Reference Indicators
Market Cap
67¥100M
P/E (Forecast)
—
P/B
1.7x
Dividend Yield (Forecast)
0.00%
ROE
-30.4%
EV/EBITDA
—
Financial Summary
Unit: ¥M
| Item | 2021Sep 2021 | 2022Sep 2022 | 2023Sep 2023 | 2024Sep 2024 | 2025Sep 2025 |
|---|---|---|---|---|---|
Net Sales | 683 | 633 | 661 | 768 | 810 |
Cost of Sales | 502 | 505 | 563 | 655 | 700 |
Gross Profit | 180 | 127 | 98 | 112 | 109 |
SG&A Expenses | 1,261 | 1,461 | 1,524 | 1,497 | 1,555 |
Operating Income | -1,080 | -1,333 | -1,425 | -1,384 | -1,445 |
Non-operating Income | 221 | 26 | 26 | 130 | 108 |
Non-operating Expenses | 11 | 7 | 19 | 7 | 2 |
Ordinary Income | -870 | -1,314 | -1,419 | -1,261 | -1,339 |
Extraordinary Income | 32 | 66 | 6 | — | 7 |
Extraordinary Losses | — | 0 | 21 | 11 | 25 |
Pre-tax Income | -838 | -1,248 | -1,433 | -1,273 | -1,357 |
Income Taxes | 5 | 5 | 4 | 3 | 4 |
Net Income | -843 | -1,254 | -1,437 | -1,276 | -1,362 |
EBITDA | -965 | -1,227 | -1,322 | -1,270 | -1,343 |
Gross Margin | 26.4% | 20.2% | 14.9% | 14.7% | 13.5% |
Operating Margin | -158.2% | -210.4% | -215.5% | -180.2% | -178.4% |
ROA | -15.7% | -20.6% | -25.5% | -22.4% | -32.0% |
ROE | -17.5% | -24.1% | -27.3% | -25.0% | -30.4% |
Segment Performance
Unit: ¥M
2025
| Segment | Net Sales | Operating Income | Operating Margin |
|---|---|---|---|
| 細胞加工業 | 810 | -474 | -58.5% |
| 再生医療等製品事業 | 0 | -407 | 0.0% |